Paolo Marchetti

18.4k total citations
454 papers, 8.5k citations indexed

About

Paolo Marchetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Paolo Marchetti has authored 454 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 254 papers in Oncology, 141 papers in Pulmonary and Respiratory Medicine and 73 papers in Molecular Biology. Recurrent topics in Paolo Marchetti's work include Cancer Immunotherapy and Biomarkers (77 papers), Colorectal Cancer Treatments and Studies (51 papers) and Cancer Treatment and Pharmacology (51 papers). Paolo Marchetti is often cited by papers focused on Cancer Immunotherapy and Biomarkers (77 papers), Colorectal Cancer Treatments and Studies (51 papers) and Cancer Treatment and Pharmacology (51 papers). Paolo Marchetti collaborates with scholars based in Italy, United States and Malaysia. Paolo Marchetti's co-authors include Andrea Botticelli, Michela Roberto, Federica Mazzuca, Agnese Barnabei, Francesco Torino, Salvatore Maria Corsello, Marianna Nuti, Corrado Ficorella, Ilaria Grazia Zizzari and Roberto Salvatori and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Paolo Marchetti

435 papers receiving 8.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Marchetti Italy	44	4.6k	2.1k	1.8k	1.2k	970	454	8.5k
Óscar Arrieta Mexico	48	3.7k 0.8×	2.3k 1.1×	3.2k 1.8×	710 0.6×	1.5k 1.5×	390	8.4k
Urania Dafni Greece	48	3.1k 0.7×	934 0.4×	1.7k 0.9×	727 0.6×	703 0.7×	157	7.5k
Anita Giobbie‐Hurder United States	54	5.4k 1.2×	2.0k 1.0×	2.1k 1.2×	1.7k 1.5×	1.4k 1.5×	222	11.0k
Rainer Kimmig Germany	52	3.6k 0.8×	2.2k 1.1×	1.2k 0.7×	1.2k 1.0×	2.3k 2.4×	402	10.3k
Michael J. Schell United States	45	3.2k 0.7×	1.6k 0.8×	1.9k 1.1×	549 0.5×	726 0.7×	171	6.4k
Emanuela Scarpi Italy	46	3.5k 0.8×	1.2k 0.6×	1.8k 1.0×	445 0.4×	1.4k 1.5×	265	7.0k
Lynette M. Smith United States	53	2.9k 0.6×	2.1k 1.0×	1.3k 0.7×	935 0.8×	873 0.9×	299	8.8k
Helmut Friess Germany	48	3.1k 0.7×	1.8k 0.9×	1.0k 0.6×	909 0.8×	990 1.0×	253	7.6k
King‐Jen Chang Taiwan	60	3.7k 0.8×	4.1k 2.0×	1.7k 0.9×	912 0.8×	2.4k 2.5×	336	11.2k
Toru Watanabe Japan	44	2.0k 0.4×	1.9k 0.9×	966 0.5×	727 0.6×	567 0.6×	341	7.9k

Countries citing papers authored by Paolo Marchetti

Since Specialization

Citations

This map shows the geographic impact of Paolo Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Marchetti more than expected).

Fields of papers citing papers by Paolo Marchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Marchetti. The network helps show where Paolo Marchetti may publish in the future.

Co-authorship network of co-authors of Paolo Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Marchetti. A scholar is included among the top collaborators of Paolo Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Marchetti. Paolo Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Altini, Mattia, Gianni Amunni, Ovidio Brignoli, et al.. (2025). Real World Evidence in Oncology: An Italian examples-based Expert Opinion on Advancing Clinical and Regulatory Decision-Making. 5(1). 7–7. 1 indexed citations

Cirillo, Alessio, Daniele Marinelli, Umberto Romeo, et al.. (2024). Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis. BMC Cancer. 24(1). 430–430. 4 indexed citations

Giacomo, Anna Maria Di, Michele Del Vecchio, Pier Francesco Ferrucci, et al.. (2023). 1084MO Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial. Annals of Oncology. 34. S653–S654. 2 indexed citations

Normanno, Nicola, Antonella De Luca, Riziero Esposito Abate, et al.. (2023). Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study. European Journal of Cancer. 187. 174–184. 9 indexed citations

Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, et al.. (2023). Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 24(8). 7114–7114. 9 indexed citations

Roberto, Michela, Emanuela Pilozzi, Genoveffa Balducci, et al.. (2022). The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study. SHILAP Revista de lepidopterología. 4 indexed citations

Zizzari, Ilaria Grazia, Andrea Botticelli, Lidia Strigari, et al.. (2022). Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer. Clinical Cancer Research. 28(5). 1027–1037. 21 indexed citations

Giacomo, Anna Maria Di, Vanna Chiarion‐Sileni, Michele Del Vecchio, et al.. (2021). Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases. Clinical Cancer Research. 27(17). 4737–4745. 41 indexed citations

Fania, Luca, Roberto Morese, Giovanni Di Lella, et al.. (2020). Il percorso diagnostico-terapeutico e assistenziale nella gestione del paziente affetto da tumore cutaneo non melanocitario: l’esperienza dell’IDI - IRCCS di Roma. Recenti Progressi in Medicina. 111(12). 749–760. 1 indexed citations

10.

Pizzuti, Laura, Eriseld Krasniqi, Chiara Mandoj, et al.. (2020). Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial. Cancers. 12(4). 849–849. 2 indexed citations

11.

Belleudi, Valeria, et al.. (2019). Utilizzo appropriato del trastuzumab nel Lazio: scenari terapeutici e stima del possibile risparmio per il Servizio Sanitario Regionale. Recenti Progressi in Medicina. 110(12). 604–614. 1 indexed citations

12.

Cerbelli, Bruna, Andrea Botticelli, Annalinda Pisano, et al.. (2019). CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(4). 569–576. 27 indexed citations

13.

Mazzuca, Federica, Maria Rinzivillo, Emanuela Pilozzi, et al.. (2019). Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center. Journal of Clinical Medicine. 8(6). 910–910. 32 indexed citations

14.

Zizzari, Ilaria Grazia, Chiara Napoletano, Andrea Botticelli, et al.. (2018). TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway. Cancer Immunology Research. 6(6). 711–722. 51 indexed citations

15.

Botticelli, Andrea, Bruna Cerbelli, Luana Lionetto, et al.. (2018). The key role of kynurenine in antiPD-1 failure. Open Repository and Bibliography (University of Liège). 1 indexed citations

16.

Cerbelli, Bruna, Angelina Pernazza, Andrea Botticelli, et al.. (2017). PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?. BioMed Research International. 2017. 1–7. 48 indexed citations

17.

Marchetti, Paolo. (2015). “Perchance to dream”. Personality modifications and criminal liability : a nineteenth-century debate between psychiatry and law. Crime Histoire et Sociétés. 19(2). 77–91. 1 indexed citations

18.

Romiti, Adriana, Massimo Milione, Luigi Ruco, et al.. (2012). Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.. PubMed. 32(1). 115–9. 4 indexed citations

19.

Marchetti, Paolo. (2004). Recensione a Michael Hardt, Antonio Negri, Moltitudine. Guerra e democrazia nel nuovo ordine imperiale. UniTERAMO Research Catalog (University of Teramo).

20.

Marchetti, Paolo. (2001). De iure finium : diritto e confini tra tardo Medievo ed età moderna. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact